BioLife Solutions, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
BioLife Solutions, Inc. (BLFS) holds an ST Score of 55.7 out of 100 (B-), with its strongest factor being Financial Strength (A+) and its weakest Forecast (D+). Analysts rate BLFS Buy across 18 ratings with a $31.00 average price target (-0.2% vs the current $37.18).
- Strongest
- Financial StrengthA+
- Weakest
- ForecastD+
All factor grades
- Financial StrengthA+
- ProfitabilityB+
- MomentumB+
- ValuationC
- GrowthC-
- ForecastD+
- Piotroski5/9
Contact
BLFS stock: frequently asked questions
What is BLFS's ST Score?
BioLife Solutions, Inc. (BLFS) has an ST Score of 55.7 out of 100, an overall grade of B-. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BLFS a buy, sell, or hold?
Wall Street's consensus rating on BLFS is Buy based on 18 analyst ratings. Our own ST Score grades it B- (55.7/100). This is data, not investment advice — always do your own research.
What is BLFS's valuation grade?
BioLife Solutions, Inc. (BLFS) earns a valuation grade of C, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BLFS's growth grade?
BioLife Solutions, Inc. (BLFS) earns a growth grade of C-, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BLFS's profitability grade?
BioLife Solutions, Inc. (BLFS) earns a profitability grade of B+, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BLFS's financial strength grade?
BioLife Solutions, Inc. (BLFS) earns a financial strength grade of A+, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BLFS?
The average analyst price target for BioLife Solutions, Inc. (BLFS) is $31.00 from 18 analysts, which is -0.2% versus the recent price of $37.18.
What is BLFS's Piotroski score?
BioLife Solutions, Inc. (BLFS) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.